Clin2
NCT07455084Possibly a fitNot yet recruiting

Tracking how a new drug leaves the body in healthy men

Schizophrenia

Part of Mental health clinical trials.

This study gives healthy men a single dose of a new medication that has a tiny radioactive marker, so researchers can track how it leaves the body through urine and stool. It helps understand how the drug is processed and safe, which is a necessary step before it can be tested in patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a healthy male adult between 18 and 55 years old.
  • Your body mass index (BMI) is between 18 and 32.
  • You have regular daily bowel movements (at least one per day).
  • You have no major heart problems, like irregular heartbeat or heart failure.
  • You have not taken part in another clinical trial recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07225712Recruiting· Phase 3
Long-term study of an experimental drug for stable schizophrenia

This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.

Fukuoka
NCT07585383Not yet recruiting· Phase 1
Testing a new capsule for safety in healthy volunteers

This study tests a new medicine, KR23248, in healthy people to see if it is safe and how the body handles it. It is a first-in-human trial, so the main goal is to find out about side effects and how the drug moves through the body.

NCT07460284Not yet recruiting· Phase 1
Tracing how a study drug moves through healthy men

This study gives healthy people a single shot of a study drug that has a tiny radioactive label, then tracks how it moves through the body. It helps researchers learn how the drug is absorbed and removed, which is a key step before it can be tested as a possible treatment for weight-related conditions.

Jinan, Shandong
NCT07025915Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.

NCT07857265Not yet recruiting· Phase 1
Tracking a new medicine in healthy men

This study gives healthy men a single dose of a new medicine to see how the body absorbs, uses, and removes it over time. It helps researchers understand the drug's safety and behavior before it is tested in patients.

NCT07764705Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.